CAY10603 (Standard)
CAY10603 (Standard) is the analytical standard of CAY10603. This product is intended for research and analytical applications. CAY10603 (BML-281) is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 (BML-281) also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 95%
- No. CAS: 1045792-66-2
- Fòrmula: C22H30N4O6
- Peso molecular:446.50
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-18613
CAY10603HDAC Inhibitor -
HY-15144
Trichostatin AHDAC Class I/II Inhibitor -
HY-13428
TubacinHDAC6 Inhibitor -
HY-10224
PanobinostatHDAC Inhibitor -
HY-16026
RicolinostatHDAC6 Inhibitor -
HY-13909
RGFP966HDAC3 Inhibitor -
HY-13606
DacinostatAutophagy Inducer -
HY-13271A
Tubastatin AHDAC6 Inhibitor -
HY-15149
RomidepsinHDAC Inhibitor -
HY-16425
RG2833HDAC1/3 Inhibitor -
HY-10585
Valproic acidHDAC Inhibitor -
HY-10221
VorinostatHDAC Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 1045792-66-2
-
Peso molecular 446.50
-
Fòrmula C22H30N4O6
-
SMILES
O=C(OC(C)(C)C)NC1=CC=C(C2=CC(C(NCCCCCCC(NO)=O)=O)=NO2)C=C1
-
Synonyms
BML-281 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Kozikowski AP, et al. Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. J Med Chem. 2008 Aug 14;51(15):4370-3. [Content Brief]
[2]. Wang Z, et al. HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma. Oncol Rep. 2016 Jul;36(1):589-97. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
CAY10603 (Standard) Related Classifications
HY-18613R Related Classifications
Powered by Bioz